Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MAP3K7 |
| Upstream (Parents) |
|---|
| (<<) BAD → MAP3K7 |
| (<<) CASP9 → MAP3K7 |
| (<<) CLPP → MAP3K7 |
| (<<) ELF2 → MAP3K7 |
| (<<) ELOVL1 → MAP3K7 |
| (<<) GNB2 → MAP3K7 |
| (<<) MYL9 → MAP3K7 |
| (<<) PIK3R5 → MAP3K7 |
| (<<) PLD3 → MAP3K7 |
| (<<) PPIB → MAP3K7 |
| (<<) SEPW1 → MAP3K7 |
| (<<) THRB → MAP3K7 |
| Downstream (Children) |
|---|
| MAP3K7 → ATN1 (>>) |
| MAP3K7 → ATP2B4 (>>) |
| MAP3K7 → ATP7B (>>) |
| MAP3K7 → CASP10 (>>) |
| MAP3K7 → CHST7 (>>) |
| MAP3K7 → DDX21 (>>) |
| MAP3K7 → DMPK (>>) |
| MAP3K7 → DNAJA4 (>>) |
| MAP3K7 → DUSP5 (>>) |
| MAP3K7 → EIF2C2 (>>) |
| MAP3K7 → FZD4 (>>) |
| MAP3K7 → GLTPD1 (>>) |
| MAP3K7 → GNAS (>>) |
| MAP3K7 → GNE (>>) |
| MAP3K7 → GRHPR (>>) |
| MAP3K7 → GRK5 (>>) |
| MAP3K7 → HDAC3 (>>) |
| MAP3K7 → HPCAL1 (>>) |
| MAP3K7 → HSPC159 (>>) |
| MAP3K7 → IL1F7 (>>) |
| MAP3K7 → INPP5D (>>) |
| MAP3K7 → KCNJ2 (>>) |
| MAP3K7 → MAP1B (>>) |
| MAP3K7 → MMP25 (>>) |
| MAP3K7 → MYL3 (>>) |
| MAP3K7 → NCOA3 (>>) |
| MAP3K7 → PDGFB (>>) |
| MAP3K7 → PIK3C2B (>>) |
| MAP3K7 → PITPNA (>>) |
| MAP3K7 → PPP2R5C (>>) |
| MAP3K7 → PTMS (>>) |
| MAP3K7 → PYGB (>>) |
| MAP3K7 → RPL36 (>>) |
| MAP3K7 → RRP9 (>>) |
| MAP3K7 → RXRA (>>) |
| MAP3K7 → SESN1 (>>) |
| MAP3K7 → SFN (>>) |
| MAP3K7 → SH3GL1 (>>) |
| MAP3K7 → SPPL2B (>>) |
| MAP3K7 → SPRR1B (>>) |
| MAP3K7 → TGFA (>>) |
| MAP3K7 → TIMP2 (>>) |
| MAP3K7 → TK2 (>>) |
| MAP3K7 → TMPRSS11D (>>) |
| MAP3K7 → WNT5B (>>) |
| MAP3K7 → ZBED2 (>>) |
